Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

A novel highly potent therapeutic antibody neutralizes multiple human chemokines and mimics viral immune modulation.

Scalley-Kim ML, Hess BW, Kelly RL, Krostag AR, Lustig KH, Marken JS, Ovendale PJ, Posey AR, Smolak PJ, Taylor JD, Wood CL, Bienvenue DL, Probst P, Salmon RA, Allison DS, Foy TM, Raport CJ.

PLoS One. 2012;7(8):e43332. doi: 10.1371/journal.pone.0043332. Epub 2012 Aug 17.

2.

Identification and characterization of novel recombinant vaccine antigens for immunization against genital Chlamydia trachomatis.

Coler RN, Bhatia A, Maisonneuve JF, Probst P, Barth B, Ovendale P, Fang H, Alderson M, Lobet Y, Cohen J, Mettens P, Reed SG.

FEMS Immunol Med Microbiol. 2009 Mar;55(2):258-70. doi: 10.1111/j.1574-695X.2008.00527.x.

3.

Unique model of dormant infection for tuberculosis vaccine development.

Kashino SS, Ovendale P, Izzo A, Campos-Neto A.

Clin Vaccine Immunol. 2006 Sep;13(9):1014-21.

4.

Secreted proteins from Mycobacterium tuberculosis gain access to the cytosolic MHC class-I antigen-processing pathway.

Lewinsohn DM, Grotzke JE, Heinzel AS, Zhu L, Ovendale PJ, Johnson M, Alderson MR.

J Immunol. 2006 Jul 1;177(1):437-42.

5.

Protection of mice and guinea pigs against tuberculosis induced by immunization with a single Mycobacterium tuberculosis recombinant antigen, MTB41.

Skeiky YA, Alderson MR, Ovendale PJ, Lobet Y, Dalemans W, Orme IM, Reed SG, Campos-Neto A.

Vaccine. 2005 Jun 10;23(30):3937-45. Epub 2005 Mar 30.

PMID:
15917115
6.
7.

Differential immune responses and protective efficacy induced by components of a tuberculosis polyprotein vaccine, Mtb72F, delivered as naked DNA or recombinant protein.

Skeiky YA, Alderson MR, Ovendale PJ, Guderian JA, Brandt L, Dillon DC, Campos-Neto A, Lobet Y, Dalemans W, Orme IM, Reed SG.

J Immunol. 2004 Jun 15;172(12):7618-28.

8.

An inclusion membrane protein from Chlamydia trachomatis enters the MHC class I pathway and stimulates a CD8+ T cell response.

Starnbach MN, Loomis WP, Ovendale P, Regan D, Hess B, Alderson MR, Fling SP.

J Immunol. 2003 Nov 1;171(9):4742-9.

9.

Cloning and characterization of a gene encoding an immunoglobulin-binding receptor on the cell surface of some members of the family Trypanosomatidae.

Campos-Neto A, Suffia I, Cavassani KA, Jen S, Greeson K, Ovendale P, Silva JS, Reed SG, Skeiky YA.

Infect Immun. 2003 Sep;71(9):5065-76.

10.

Evaluation of DPPD, a single recombinant Mycobacterium tuberculosis protein as an alternative antigen for the Mantoux test.

Campos-Neto A, Rodrigues-Júnior V, Pedral-Sampaio DB, Netto EM, Ovendale PJ, Coler RN, Skeiky YA, Badaró R, Reed SG.

Tuberculosis (Edinb). 2001;81(5-6):353-8.

PMID:
11800586
11.

Vaccination with the T cell antigen Mtb 8.4 protects against challenge with Mycobacterium tuberculosis.

Coler RN, Campos-Neto A, Ovendale P, Day FH, Fling SP, Zhu L, Serbina N, Flynn JL, Reed SG, Alderson MR.

J Immunol. 2001 May 15;166(10):6227-35.

12.

T cell expression cloning of a Mycobacterium tuberculosis gene encoding a protective antigen associated with the early control of infection.

Skeiky YA, Ovendale PJ, Jen S, Alderson MR, Dillon DC, Smith S, Wilson CB, Orme IM, Reed SG, Campos-Neto A.

J Immunol. 2000 Dec 15;165(12):7140-9.

13.

Cloning of a Mycobacterium tuberculosis gene encoding a purifed protein derivative protein that elicits strong tuberculosis-specific delayed-type hypersensitivity.

Coler RN, Skeiky YA, Ovendale PJ, Vedvick TS, Gervassi L, Guderian J, Jen S, Reed SG, Campos-Neto A.

J Infect Dis. 2000 Jul;182(1):224-33. Epub 2000 Jul 6.

PMID:
10882601
14.

LeIF: a recombinant Leishmania protein that induces an IL-12-mediated Th1 cytokine profile.

Skeiky YA, Kennedy M, Kaufman D, Borges MM, Guderian JA, Scholler JK, Ovendale PJ, Picha KS, Morrissey PJ, Grabstein KH, Campos-Neto A, Reed SG.

J Immunol. 1998 Dec 1;161(11):6171-9.

15.

Molecular cloning and immunologic reactivity of a novel low molecular mass antigen of Mycobacterium tuberculosis.

Coler RN, Skeiky YA, Vedvick T, Bement T, Ovendale P, Campos-Neto A, Alderson MR, Reed SG.

J Immunol. 1998 Sep 1;161(5):2356-64.

16.

Molecular cloning, expression, and immunogenicity of MTB12, a novel low-molecular-weight antigen secreted by Mycobacterium tuberculosis.

Webb JR, Vedvick TS, Alderson MR, Guderian JA, Jen SS, Ovendale PJ, Johnson SM, Reed SG, Skeiky YA.

Infect Immun. 1998 Sep;66(9):4208-14.

17.

Human and murine immune responses to a novel Leishmania major recombinant protein encoded by members of a multicopy gene family.

Webb JR, Campos-Neto A, Ovendale PJ, Martin TI, Stromberg EJ, Badaro R, Reed SG.

Infect Immun. 1998 Jul;66(7):3279-89.

18.

CD40 ligand is not essential for the development of cell-mediated immunity and resistance to Mycobacterium tuberculosis.

Campos-Neto A, Ovendale P, Bement T, Koppi TA, Fanslow WC, Rossi MA, Alderson MR.

J Immunol. 1998 Mar 1;160(5):2037-41.

19.

CD40 ligand is required for protective cell-mediated immunity to Leishmania major.

Campbell KA, Ovendale PJ, Kennedy MK, Fanslow WC, Reed SG, Maliszewski CR.

Immunity. 1996 Mar;4(3):283-9.

Supplemental Content

Loading ...
Support Center